PMID- 14592444 OWN - NLM STAT- MEDLINE DCOM- 20040210 LR - 20190612 IS - 0006-291X (Print) IS - 0006-291X (Linking) VI - 311 IP - 2 DP - 2003 Nov 14 TI - Suppressor mechanism of serum thymic factor on tumor necrosis factor-alpha-induced apoptosis in the mouse pancreatic beta-cell line. PG - 501-5 AB - Tumor necrosis factor-alpha (TNF-alpha) is a cytokine considered to play a key role in beta-cell destruction in insulin-dependent diabetes mellitus (IDDM). Serum thymic factor (Facteur thymique serique; FTS) is a nonapeptide thymus hormone known to inhibit IDDM in a mouse model. In this study, the effect of TNF-alpha on the murine pancreatic beta-cell line MIN6 was examined. Cell shrinkage and detachment were seen in cells treated with 0-50 ng/ml TNF-alpha for 12h. Oligonucleosomal DNA fragmentation was determined from non-adherent cells, indicating that the TNF-alpha-induced cell destruction was attributed to apoptosis. Fragmented DNA was quantified by enzyme-linked immunosorbent assay to measure the amount of histone-bound oligonucleosomes. FTS was treated with TNF-alpha and the percentage of fragmented DNA was analyzed. The data indicate a distinct reduction of fragmented DNA at a concentration of 1 ng/ml FTS. Expression of TNF receptor I, inducible form of nitric oxide synthase (iNOS), interleukin-1 beta-converting enzyme (ICE), Bcl-2, and nuclear factor kappa B (NF-kappa B) was analyzed by reverse transcriptase-polymerase chain reaction to investigate the suppressor mechanism of FTS on TNF-alpha-induced apoptosis. FTS treatment suppressed the expression of iNOS and Bcl-2 mRNA in TNF-alpha-treated cells. The expression of NF-kappa B mRNA in TNF-alpha-treated cells was enhanced after FTS treatment, while that of ICE mRNA did not change in TNF-alpha-treated cells with or without FTS treatment. These results suggest that the inhibition of MIN6 cell death by FTS on TNF-alpha-induced apoptosis is caused by a negative feedback mechanism involving the inhibition of iNOS induction. FAU - Yasuda, Junko AU - Yasuda J AD - Department of Molecular Immunology, School of Agricultural and Life Sciences, University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan. FAU - Nishioka, Wakako AU - Nishioka W FAU - Sakudo, Akikazu AU - Sakudo A FAU - Yama, Sachiko AU - Yama S FAU - Setoguchi, Ruka AU - Setoguchi R FAU - Saeki, Keiichi AU - Saeki K FAU - Matsumoto, Yoshitsugu AU - Matsumoto Y FAU - Awaya, Akira AU - Awaya A FAU - Onodera, Takashi AU - Onodera T LA - eng PT - Journal Article PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Tumor Necrosis Factor-alpha) RN - 9H198D04WL (Thymic Factor, Circulating) SB - IM MH - Animals MH - Apoptosis/*drug effects MH - Cell Line MH - DNA Damage MH - Dose-Response Relationship, Drug MH - Drug Interactions MH - Islets of Langerhans/cytology/*drug effects/*metabolism MH - Mice MH - Thymic Factor, Circulating/*pharmacology MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 2003/11/01 05:00 MHDA- 2004/02/11 05:00 CRDT- 2003/11/01 05:00 PHST- 2003/11/01 05:00 [pubmed] PHST- 2004/02/11 05:00 [medline] PHST- 2003/11/01 05:00 [entrez] AID - S0006291X03021053 [pii] AID - 10.1016/j.bbrc.2003.10.025 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2003 Nov 14;311(2):501-5. doi: 10.1016/j.bbrc.2003.10.025.